Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.000001 par value per share
-
Shares outstanding
-
6,567,164
-
Total 13F shares
-
89,280,197
-
Share change
-
-10,403,488
-
Total reported value
-
$56,246,846
-
Put/Call ratio
-
24%
-
Price per share
-
$0.63
-
Number of holders
-
70
-
Value change
-
-$78,926,949
-
Number of buys
-
39
-
Number of sells
-
48
Institutional Holders of Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) as of Q4 2022
As of 31 Dec 2022,
Instil Bio, Inc. - Common Stock, $0.000001 par value per share (TIL) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,280,197 shares.
The largest 10 holders included
Curative Ventures V LLC, Vivo Capital, LLC, CPMG Inc, BAKER BROS. ADVISORS LP, BlackRock Inc., VANGUARD GROUP INC, Samsara BioCapital, LLC, MARSHALL WACE, LLP, STATE STREET CORP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
71
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.